These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 23328978)
1. Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations. Kim SA; Kwak J; Nam HY; Chun SM; Lee BW; Lee HJ; Khang SK; Kim SW Mod Pathol; 2013 May; 26(5):626-39. PubMed ID: 23328978 [TBL] [Abstract][Full Text] [Related]
2. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305 [TBL] [Abstract][Full Text] [Related]
3. The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence. Lambiv WL; Vassallo I; Delorenzi M; Shay T; Diserens AC; Misra A; Feuerstein B; Murat A; Migliavacca E; Hamou MF; Sciuscio D; Burger R; Domany E; Stupp R; Hegi ME Neuro Oncol; 2011 Jul; 13(7):736-47. PubMed ID: 21642372 [TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Chan SL; Cui Y; van Hasselt A; Li H; Srivastava G; Jin H; Ng KM; Wang Y; Lee KY; Tsao GS; Zhong S; Robertson KD; Rha SY; Chan AT; Tao Q Lab Invest; 2007 Jul; 87(7):644-50. PubMed ID: 17384664 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of WIF-1 by hypermethylation in astrocytomas. Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y; Song T; Zeng F; Rao Y Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):418-25. PubMed ID: 20539942 [TBL] [Abstract][Full Text] [Related]
6. WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix. Delmas AL; Riggs BM; Pardo CE; Dyer LM; Darst RP; Izumchenko EG; Monroe M; Hakam A; Kladde MP; Siegel EM; Brown KD Carcinogenesis; 2011 Nov; 32(11):1625-33. PubMed ID: 21873353 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma. Yang SH; Li SL; Dong ZM; Kan QC Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918 [TBL] [Abstract][Full Text] [Related]
8. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis. Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791 [TBL] [Abstract][Full Text] [Related]
9. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival. Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617 [TBL] [Abstract][Full Text] [Related]
10. c‑Jun suppresses the expression of WNT inhibitory factor 1 through transcriptional regulation and interaction with DNA methyltransferase 1 in gallbladder cancer. Lin B; Hong H; Jiang X; Li C; Zhu S; Tang N; Wang X; She F; Chen Y Mol Med Rep; 2018 Jun; 17(6):8180-8188. PubMed ID: 29693707 [TBL] [Abstract][Full Text] [Related]
11. Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas. Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y J Exp Clin Cancer Res; 2010 Mar; 29(1):26. PubMed ID: 20334650 [TBL] [Abstract][Full Text] [Related]
12. WIF1 was downregulated in cervical cancer due to promoter methylation. Wang Y; Yuan S; Ma J; Liu H; Huang L; Zhang F; Wang X Acta Biochim Pol; 2023 Jun; 70(2):419-423. PubMed ID: 37306343 [TBL] [Abstract][Full Text] [Related]
13. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor. Mitsui Y; Yasumoto H; Nagami T; Hiraki M; Arichi N; Ishikawa N; Araki A; Maruyama R; Tanaka Y; Dahiya R; Shiina H Oncotarget; 2014 Apr; 5(8):2198-207. PubMed ID: 24755523 [TBL] [Abstract][Full Text] [Related]
14. Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma. Liu P; Shen JK; Hornicek FJ; Liu F; Duan Z Sci Rep; 2017 May; 7(1):1580. PubMed ID: 28484252 [TBL] [Abstract][Full Text] [Related]
15. WIF1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway. Zhang B; Ji J; Hu M; Zhou X; Nie Q; Xu H; Jiang C; Fu Y; Li L Am J Reprod Immunol; 2023 Aug; 90(2):e13743. PubMed ID: 37491917 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252 [TBL] [Abstract][Full Text] [Related]
17. Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence. Ramachandran I; Ganapathy V; Gillies E; Fonseca I; Sureban SM; Houchen CW; Reis A; Queimado L Cell Death Dis; 2014 May; 5(5):e1246. PubMed ID: 24853424 [TBL] [Abstract][Full Text] [Related]
18. Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients. Trifa F; Karray-Chouayekh S; Jmal E; Jmaa ZB; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R Tumour Biol; 2013 Jun; 34(3):1625-33. PubMed ID: 23417837 [TBL] [Abstract][Full Text] [Related]
19. Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma. Alshareef A; Peters AC; Gélébart P; Chen W; Lai R Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477402 [TBL] [Abstract][Full Text] [Related]